Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 17, 2012 12:05 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Issues Statement Regarding Registration of Shares Related to Finesco/Scomedica and PediatRx Transactions

SAN DIEGO, July 17, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (www.apricusbio.com) today issued the following statement regarding the registration of 3,706,397...
July 13, 2012 10:03 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Closing of Finesco-Scomedica Transaction

SAN DIEGO, July 13, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (www.apricusbio.com) today announced the closing of its agreement to own Finesco, the French parent...
July 02, 2012 10:45 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences' CEO to Present at the JMP Securities Healthcare Conference

SAN DIEGO, July 2, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (www.apricusbio.com) announced today that Bassam Damaj, Ph.D., President and Chief Executive...
June 20, 2012 16:01 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Own Revenue Generating Leading French Drug Sales & Marketing Company

Ownership of Finesco-Scomedica will allow Apricus Bio to directly launch Vitaros® and its other products in France, Europe's second-largest drug market Conference Call/Webcast to be Held...
June 15, 2012 09:52 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at 2012 BIO International Convention

SAN DIEGO, June 15, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or "the Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Bassam Damaj, Ph.D., President...
June 14, 2012 09:36 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Submits Response to Swissmedic for Its Vitaros(R) Market Application for Erectile Dysfunction

SAN DIEGO, June 14, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or "the Company") (Nasdaq:APRI) (www.apricusbio.com) today announced that the Company has filed its response to...
June 04, 2012 09:39 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Appointment of Paul V. Maier to Its Board of Directors

SAN DIEGO, June 4, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (www.apricusbio.com) today announced that Paul V. Maier, Chief Financial Officer of Sequenom, Inc.,...
May 29, 2012 09:35 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences' CEO to Present at the 2012 Jefferies Global Healthcare Conference

SAN DIEGO, May 29, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that Bassam Damaj, Ph.D., President and Chief Executive Officer, will present at the...
May 25, 2012 13:21 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Strengthens Vitaros(R) and Nexact(R) Patent Estate With Two New Patent Allowances

SAN DIEGO, May 25, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that the Canadian Intellectual Property...
May 22, 2012 10:13 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Granted Regulatory Guidance With FDA for MycoVa(TM) for the Treatment of Onychomycosis

SAN DIEGO, May 22, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that the United States ("U.S.") Food...